Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,164
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Dayton OH, Louisville KY, Indianapolis IN, Columbus OH,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase3, Recruiting
Comparing Prism Adaptation Training With and Without TENS to Minimize Unilateral Spatial Neglect
for
Unilateral Spatial Neglect, Stroke
Location: Centerville OH
Sponsor: Kettering Health Network
Sex: All
Age: 18+
Code: NCT07157865
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Location: Edgewood KY, Mount Orab OH, Dayton OH, Louisville KY,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Springboro OH, Akron OH, Chattanooga TN, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221188
Phase3, Recruiting
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Springboro OH, Westlake OH, Little Rock AR, Dallas TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07704892
Phase3, Recruiting
Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
for
Sarcoidosis, Pulmonary Hypertension
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 18 - 70+
Code: NCT01467791
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Location: Springboro OH, Columbus OH, South Bend IN, Westlake OH,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632444
Phase3, Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
for
Metabolic Dysfunction Associated Steatohepatitis
Location: Springboro OH, Columbus OH, South Bend IN, Westlake OH,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632457
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Lexington KY, Indianapolis IN, Corbin KY, Danville IL,
Influence of Aerobic Training and Weight Loss on Skeletal Muscle Inflammatory Markers and Muscle Protein Balance in Older Adults
for
Overweight and Obesity, Inflammation; Muscle,
Location: Oxford OH
Sponsor: Miami University
Sex: All
Age: 58+
Code: NCT03743675
Recruiting
Narrative Comprehension by People With Acquired Brain Injury
for
Aphasia, Traumatic Brain Injury
Location: Oxford OH
Sponsor: Miami University
Sex: All
Age: 19 - 70+
Code: NCT03309930
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: Franklin OH, Kettering OH, Newark OH, Beavercreek OH,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors